HM Hospitales se alía con Myocardial Solutions para valorar la cardiotoxicidad de la quimioterapia y la función cardiaca de los pacientes oncológico
• HM Sanchinarro, through HM CIEC and HM CIOCC, becomes the first private hospital in Spain to address cardio oncology through the implementation of the MyoStrain AI